Pharmasset Inc - FORM 10-K - EX-32.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350 - November 25, 2009

Attached files

file filename
EX-31.2 - CERTIFICATION OF CFO PURSUANT TO RULE 13A-14(A)/RULE 15D-14(A) - Pharmasset Incdex312.htm
EX-23.1 - CONSENT OF GRANT THORTON LLP - Pharmasset Incdex231.htm
EX-31.1 - CERTIFICATION OF CEO PURSUANT TO RULE 13A-14(A)/RULE 15D-14(A) - Pharmasset Incdex311.htm
10-K - FORM 10-K - Pharmasset Incd10k.htm
EX-32.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350 - Pharmasset Incdex321.htm

EXHIBIT 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the annual report on Form 10-K of Pharmasset, Inc. (the “Company”) for the year ended September 30, 2009 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, Kurt Leutzinger, Chief Financial Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted by Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

  (1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

  (2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: November 25, 2009
/s/    KURT LEUTZINGER        

Kurt Leutzinger

Chief Financial Officer

A signed original of this written statement required by Section 906 has been provided to Pharmasset, Inc. and will be retained by Pharmasset, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

Pharmasset Inc Reports

Also read